Parallax Volatility Advisers
ATRS

Parallax Volatility Advisers’s Antares Pharma, Inc. ATRS Stock Holding History

Parallax Volatility Advisers’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-22,218
Closed -$44K – 4770
2017
Q4 		$44K Buy
+22,218
New +$48.4K ﹤0.01% 3291

Other funds holding ATRS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parallax Volatility Advisers's ATRS Position: Q1 2018 in Review

Parallax Volatility Advisers sold out of Antares Pharma, Inc. (ATRS) in Q1 2018, closing a stake of 22,218 shares — an estimated $44K sold.

Parallax Volatility Advisers first reported a position in ATRS in Q4 2017 and held it in 1 quarter. The position peaked at $44K in Q4 2017. 102 funds tracked by Wall St. Rank hold ATRS as of Q1 2018.

  • Parallax Volatility Advisers reported no remaining Antares Pharma, Inc. position as of Q1 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 22,218 Antares Pharma, Inc. shares in Q1 2018, an estimated $44K.
  • Parallax Volatility Advisers first reported a position in Antares Pharma, Inc. in Q4 2017 and held it in 1 quarter.
  • Parallax Volatility Advisers's Antares Pharma, Inc. position peaked at $44K in Q4 2017.
  • 102 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2018.

Based on Parallax Volatility Advisers's 13F filing for Q1 2018, filed 15 May 2018.